Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 13F · SEC CIK 1764754

Geneos Wealth Management Inc.

Wealth managerFiled 2026-08-06 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$4.9B
Reported positions
2,475
Top holdings a year, 3 yrs
+17.1%
Assets under management
$9.2B

Geneos Wealth Management Inc. is a wealth manager that reported 2,475 positions worth $4.9B in its Q2 2026 13F, filed 2026-08-06. Its largest holdings were Ishares Tr (IVV, 3.3%), State Str Spdr S&p 500 ETF T (SPY, 2.7%), Ishares Tr (ITOT, 2.4%). A portfolio copying its top holdings returned 17.1% a year over the last 3 years, against 20.4% for the S&P 500.

Geneos Wealth Management Inc. holdings largest 50 of 2,475 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Geneos Wealth Management Inc. 13F holdings
Stock% of 13F valueShare changeReported value
IVVIshares Tr3.3%+4.0%$161.6M
SPYState Str Spdr S&p 500 ETF T2.7%-7.3%$133.7M
ITOTIshares Tr2.4%-3.9%$115.5M
USMVIshares Tr2.3%+2.9%$113.6M
VOOVanguard Index Fds2.1%+25.3%$104.1M
IWVIshares Tr1.5%-1.6%$71.6M
VNLAJanus Detroit Str Tr1.3%+2.4%$66.1M
SPLGSpdr Series Trust1.2%-3.8%$59.4M
AAPLApple Inc1.2%+7.2%$58.9M
SGOVIshares Tr1.0%+80.2%$49.6M
NSCNorfolk Southn Corporation1.0%-0.6%$47.7M
NVDANvidia Corporation0.9%+22.5%$46.0M
PVALPutnam Focused Large Capvalue ETF0.9%+3.4%$44.8M
IXUSIshares Tr0.9%+0.0%$44.2M
SPTMSpdr Series Trust0.9%+2.3%$43.2M
QQQInvesco Qqq Tr0.9%-2.5%$42.3M
SPDWSpdr Index Shs Fds0.8%+2.1%$39.7M
FIXDFirst Tr Exchng Traded Fd Vi0.8%+3.6%$38.7M
MSFTMicrosoft Corp0.8%-1.0%$37.2M
IEFAIshares Tr0.8%+0.2%$36.9M
SPYGState Street Spdr Portfolio S&p 500 Grow0.7%+0.2%$36.1M
SPYVState Street Spdr Portfolio S&p 500 Valu0.7%+0.0%$35.9M
BIVVanguard Bd Index Fds0.7%+6.9%$35.7M
FNDFSchwab Strategic Tr0.7%+4.9%$34.5M
VEAVanguard Ftse Developed Markets Index Fu0.7%+3.7%$33.8M
BRK-BBerkshire Hathaway Inc Del0.7%-5.7%$33.0M
HDEFDbx ETF Tr0.7%+0.8%$32.4M
HISFFirst Tr Exchange-Traded Fd0.7%+3.5%$32.2M
SPBOSpdr Series Trust0.6%+6.5%$31.4M
PANWPalo Alto Networks Inc0.6%—$29.7M
ISTBIshares Tr0.6%+5.3%$29.5M
AMZNAmazon Com Inc0.6%+17.1%$29.4M
DFACDimensional ETF Trust0.6%+3.1%$29.0M
DCORDimensional US Core Equity 1 ETF0.6%+3.3%$28.0M
CGGRCapital Group Growth ETF0.6%+6.7%$27.9M
VTIVanguard Index Fds0.6%+3.0%$27.5M
VXUSVanguard Star Fds0.6%—$27.3M
MOATVaneck Morningstar Wide Moat ETF0.5%+1.9%$26.8M
RSPInvesco Exchange Traded Fd T0.5%+7.8%$26.8M
CGDVCapital Group Dividend Value0.5%+3.9%$25.6M
EFAIshares Tr0.5%-0.3%$25.5M
GOOGAlphabet Inc0.5%-4.4%$25.0M
SPSMSpdr Series Trust0.5%+3.0%$24.4M
GOOGLAlphabet Inc0.5%-7.7%$24.4M
JQUAJpmorgan U.s. Quality Factor ETF0.5%—$24.0M
JPMJpmorgan Chase & Co0.5%+0.0%$23.9M
TSPAT Rowe Price Exchange-Traded0.5%-0.2%$23.7M
SPMDSpdr Series Trust0.5%+3.3%$22.8M
PULSPgim ETF Tr0.5%—$22.7M
RDVYFirst Tr Exchange Traded Fd0.5%—$22.4M

What Geneos Wealth Management Inc. bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year
+17.9% /yr
S&P 500 +20.1%
3 years
+17.1% /yr
S&P 500 +20.4%
5 years
+9.5% /yr
S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$4.9B2,475
Q1 2026$4.3B2,465
Q4 2025$4.1B2,459
Q3 2025$3.9B2,462
Q2 2025$4.1B3,109
Q1 2025$4.0B3,071
Q4 2024$2.9B2,879
Q3 2024$2.6B2,557
Q2 2024$2.3B2,053
Q1 2024$2.2B2,121
Q4 2023$2.0B2,089
Q3 2023$1.9B2,091

Questions about Geneos Wealth Management Inc.'s portfolio

What stocks does Geneos Wealth Management Inc. own?

Geneos Wealth Management Inc.'s latest 13F, for Q2 2026 and filed Aug 6, 2026, lists 2,475 positions worth $4.9B. The largest are Ishares Tr (IVV) at 3.3%, State Str Spdr S&p 500 ETF T (SPY) at 2.7%, Ishares Tr (ITOT) at 2.4%, Ishares Tr (USMV) at 2.3% and Vanguard Index Fds (VOO) at 2.1%.

What did Geneos Wealth Management Inc. buy last quarter?

In Q2 2026, Geneos Wealth Management Inc. added Ishares Tr (SGOV) (+80.2% shares), Vanguard Index Fds (VOO) (+25.3% shares) and Nvidia Corporation (NVDA) (+22.5% shares), compared with its Q1 2026 filing.

What did Geneos Wealth Management Inc. sell last quarter?

In Q2 2026, Geneos Wealth Management Inc. cut from its top 50 Exxon Mobil Corp (XOM), cut from its top 50 Spdr Series Trust (BIL), cut from its top 50 Spdr Series Trust (SPSB), cut from its top 50 Ishares Tr (GOVT), cut from its top 50 Ishares Tr (EFAV), Alphabet Inc (GOOGL) (-7.7% shares), State Str Spdr S&p 500 ETF T (SPY) (-7.3% shares) and Berkshire Hathaway Inc Del (BRK-B) (-5.7% shares), compared with its Q1 2026 filing.

How has Geneos Wealth Management Inc.'s portfolio performed?

A portfolio copying Geneos Wealth Management Inc.'s 20 largest 13F holdings each quarter, from the day each filing was public, returned +17.1% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +17.9% against +20.1%. Over 5 years: +9.5% a year against +11.6%.

When is Geneos Wealth Management Inc.'s next 13F filing due?

13F filings are due 45 days after each quarter ends. Geneos Wealth Management Inc.'s filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Geneos Wealth Management Inc. manage?

Geneos Wealth Management Inc. reported $9.2B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $4.9B.